FDA Inspection
Mohnark Pharmaceuticals IncMohnark Pharmaceuticals Inc – FDA Inspection, Feb 25, 2022
Record Details
This FDA Inspection record concerns Mohnark Pharmaceuticals Inc, with an inspection on February 25, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Mohnark Pharmaceuticals Inc
- Inspection Date
- February 25, 2022
- Product Type
- Drugs
View Company Profile
ID · 538c44e9-934f-4fb3-aec9-2f4949f7ce81
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1163035
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
- 21 CFR 211.46(b)Equipment for Environmental Control
- 21 CFR 211.84(d)(2)Reports of Analysis (Components)
- 21 CFR 211.186(b)(4)Weight or measure of each component
- 21 CFR 211.22(c)Approve or reject procedures or specs
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.